1. Home
  2. WAFU vs LABT Comparison

WAFU vs LABT Comparison

Compare WAFU & LABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WAFU

Wah Fu Education Group Limited

HOLD

Current Price

$1.39

Market Cap

5.8M

Sector

Real Estate

ML Signal

HOLD

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$1.96

Market Cap

5.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WAFU
LABT
Founded
1999
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
5.3M
IPO Year
2017
2026

Fundamental Metrics

Financial Performance
Metric
WAFU
LABT
Price
$1.39
$1.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
900.9K
210.7K
Earning Date
07-31-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.22
$1.66
52 Week High
$3.06
$6.85

Technical Indicators

Market Signals
Indicator
WAFU
LABT
Relative Strength Index (RSI) 47.89 41.23
Support Level $1.33 $1.73
Resistance Level $1.73 $2.44
Average True Range (ATR) 0.09 0.30
MACD 0.00 0.00
Stochastic Oscillator 44.11 3.36

Price Performance

Historical Comparison
WAFU
LABT

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

Share on Social Networks: